| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,675 |
11,093 |
$1.45M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,394 |
2,151 |
$996K |
| 80053 |
Comprehensive metabolic panel |
4,956 |
3,367 |
$187K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
738 |
650 |
$133K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,241 |
5,825 |
$65K |
| 80197 |
|
2,598 |
1,466 |
$65K |
| 82248 |
|
1,156 |
526 |
$44K |
| 81001 |
|
2,350 |
1,918 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,457 |
1,200 |
$42K |
| 83735 |
|
3,023 |
1,925 |
$39K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,301 |
2,433 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
676 |
635 |
$26K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
277 |
266 |
$22K |
| 84100 |
|
1,680 |
986 |
$21K |
| 87400 |
|
1,056 |
517 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
674 |
609 |
$18K |
| 94010 |
|
60 |
44 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
345 |
341 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
143 |
137 |
$7K |
| 0001A |
|
376 |
347 |
$6K |
| 86833 |
|
13 |
12 |
$6K |
| 86832 |
|
13 |
12 |
$6K |
| 81025 |
|
762 |
705 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,101 |
2,665 |
$5K |
| 80076 |
|
716 |
652 |
$4K |
| 83880 |
|
642 |
574 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
130 |
116 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
58 |
54 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
542 |
477 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
7,310 |
4,795 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
219 |
174 |
$3K |
| 0002A |
|
233 |
232 |
$3K |
| 83970 |
|
50 |
38 |
$3K |
| 84484 |
|
1,044 |
726 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
298 |
243 |
$2K |
| 87497 |
|
32 |
28 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
926 |
767 |
$2K |
| 85610 |
|
1,628 |
1,373 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31 |
27 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
13 |
$902.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
315 |
275 |
$825.85 |
| 83690 |
|
320 |
276 |
$812.74 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
130 |
125 |
$526.90 |
| 85730 |
|
488 |
436 |
$499.09 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
84 |
79 |
$496.93 |
| 86850 |
|
95 |
91 |
$470.32 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
99 |
94 |
$442.50 |
| 87081 |
|
31 |
31 |
$441.93 |
| 84702 |
|
51 |
48 |
$412.21 |
| 87807 |
|
16 |
16 |
$297.77 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
54 |
53 |
$253.62 |
| 82105 |
|
15 |
13 |
$246.02 |
| 82570 |
|
16 |
13 |
$229.32 |
| 82947 |
|
1,140 |
638 |
$224.59 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
16 |
$220.53 |
| 84156 |
|
16 |
13 |
$219.71 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
547 |
522 |
$177.93 |
| 99152 |
|
41 |
38 |
$171.82 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
101 |
84 |
$167.46 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
781 |
711 |
$163.30 |
| 86828 |
|
15 |
13 |
$106.76 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
338 |
312 |
$58.54 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
483 |
402 |
$53.02 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
699 |
634 |
$47.76 |
| 86900 |
|
102 |
95 |
$45.81 |
| 86901 |
|
98 |
91 |
$45.79 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
410 |
270 |
$35.77 |
| 87186 |
|
12 |
12 |
$34.89 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15 |
13 |
$30.72 |
| 87077 |
|
12 |
12 |
$25.80 |
| 83605 |
|
15 |
13 |
$18.46 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
45 |
39 |
$12.88 |
| 80061 |
Lipid panel |
69 |
66 |
$8.43 |
| A9270 |
Non-covered item or service |
7,519 |
4,425 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
856 |
719 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
46 |
39 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
13 |
13 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
15 |
$0.00 |
| 87799 |
|
31 |
28 |
$0.00 |
| 91300 |
|
60 |
38 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
21 |
17 |
$0.00 |